We have characterized genetic alterations at the molecular level in 49
scleroderma and 45 control families using variable number tandem repe
ats (VNTRs). Additionally, paired fibroblast cell lines from the 'affe
cted' and 'unaffected' skin and peripheral blood leucocytes of 30 pati
ents were also examined. All families in this study were typed for Cla
ss I Cw alleles and Class II-DRB, -DQA and -DQB to confirm family memb
ership. There were significant rises in the level of VNTR mutations in
scleroderma patients (36.7%, n = 18), their siblings (16.3%, n = 13)
and offspring (21.7%, n = 15). The level of VNTR mutations in the cont
rol group was 0.6% (n = 5). These mutations did not correlate with the
presence of autoantibodies and no patient was taking a known clastoge
nic drug. The most common VNTR sire for mutation was pYNZ22 (17p13.4).
Differences were also seen in the VNTR alleles between fibroblast and
lymphocyte DNA from the same patient, as measured by size alteration
of one of the alleles. We have found that VNTRs are unstable in sclero
derma patients relatives and offspring. The reason for the genomic cha
nges remains unknown, but previous studies have implicated the presenc
e of a clastogen.